- About Us
- People
-
Projects & Publications
- back
- Projects & Publications
- The ACA at 10
- Law, Policy, and Guns
- COVID-19
- Cancer
- The Elder Law Project
- The Palliative Care GPS
- Medical-Legal Partnerships
- Digital Health
- Health, Justice, and Incarceration
- Addressing the Opioid Crisis
- Brain Injury Project
- Artificial Intelligence & Robotics in Medicine
- The Prescription Podcast
- Food, Law, and Health
- Other Work
- Students
- Alumni
- News
-
Events
- back
- Events
- 2023 MLP Conference
- All 2022-2023 Events
- All 2021–2022 Events
- All 2020–2021 Events
- All 2019–2020 Events
- All 2018–2019 Events
- All 2017–2018 Events
- All 2016–2017 Events
- All 2015–2016 Events
- The Affordable Care Act at 10
- The Law and Policy of AI, Robotics, and Telemedicine in Health Care
- The Policy, Politics and Law of Cancer
- 2017 Medical-Legal Partnership Symposium
- Solomon Center Inaugural Conference
- The Law of Medicare and Medicaid at 50
- Partners
- The Solomon Center
- Events
- The Policy, Politics and Law of Cancer
February 8-9, 2018 at Yale Law School
The Solomon Center for Health Law and Policy at Yale Law School, in collaboration with Smilow Cancer Hospital and Yale Cancer Center, held a major interdisciplinary conference addressing topics at the cutting edge of cancer policy. This event brought together leading figures in the worlds of cancer care, research, regulation, and policymaking to assess the current state of cancer policy and discuss ways in which law can influence its development.
Speakers examined the role Washington, D.C. plays in cancer research and treatment—through politics, legislation, and lobbying as well as by incentivizing and protecting research—and the ways cancer policy is shaped outside the federal government, including through private entities such as cancer centers and insurance companies, and through state governments. The conference addressed special challenges in drug development and pricing as well as how cutting-edge advances in cancer treatment—including precision medicine, immunotherapy, and improvements in the genetic profiling of tumors—interface with existing and proposed government regulations. Speakers also considered how disparities and inequalities impact cancer research, regulation, and treatment.
Speakers Agenda Videos
Conference Speakers
Peter Bach, MD, MAPP: Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
Mark Barnes, JD: Partner, Ropes & Gray LLP; Visiting Lecturer, Yale Law School
Robert Bazell, PhD: Professor (Adjunct) of Molecular, Cellular, and Developmental Biology, Yale University
Edward Benz, MD: President and CEO Emeritus, Dana-Farber Cancer Institute
Gideon Blumenthal, MD: Deputy Director (acting), Office of Hematology Oncology Products, U.S. Food and Drug Administration
Otis Brawley, MD: Chief Medical Officer, American Cancer Society
Erik Fatemi: Senior Vice President, Cornerstone Government Affairs
Howard Forman, MD, MBA: Professor of Radiology and Biomedical Imaging, Public Health (Health Policy), Management, and Economics at Yale University
Charles Fuchs, MD, MPH: Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
Levi Garraway, MD, PhD: Senior Vice President, Global Development & Medical Affairs, Eli Lilly; Director, Joint Center for Cancer Precision Medicine
Abbe Gluck, JD: Professor of Law and Faculty Director, Solomon Center for Health Law and Policy, Yale Law School
Nancy Goodman, JD, MPP: Executive Director, Kids v Cancer
Cary Gross, MD: Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases), Yale School of Medicine
Peggy Hamburg, MD: Foreign Secretary, National Academy of Medicine; former Commissioner of the FDA (2009-2015)
Roy Herbst, MD, PhD: Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology, Yale School of Medicine; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
Melinda Irwin, PhD, MPH: Professor of Epidemiology (Chronic Diseases), Yale School of Public Health; Associate Director (Population Sciences), Yale Cancer Center; Co-Program Leader, Cancer Prevention and Control, Yale Cancer Center
Amy Kapczynski, JD: Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School
Rogerio Lilenbaum, MD: Professor of Medicine (Medical Oncology), Yale School of Medicine; Chief Medical Officer of Smilow Cancer Hospital
Jorge Lopez, Jr., JD: Executive Vice President and General Counsel, Memorial Sloan Kettering Cancer Center
Abe Lopman, MBA: Senior Vice President, Operations; Executive Director, Smilow Cancer Hospital at Yale New Haven
Patricia LoRusso, DO: Professor of Medicine (Medical Oncology), Yale School of Medicine; Associate Director of Experimental Therapeutics at Yale Cancer Center
Dayna Bowen Matthew, JD: William L. Matheson and Robert M. Morgenthau Distinguished Professor of Law, University of Virginia School of Law
Barbara McAneny, MD: Co-Founder and CEO, New Mexico Oncology Hematology Consultants; President-Elect, American Medical Association
Lee Newcomer, MD, MHA: Senior Vice President, Oncology, Genetics and Women’s Health, UnitedHealthcare
Randall Oyer, MD: Medical Director, Oncology Program, Lancaster General Hospital
Blase Polite, MD: Associate Professor of Medicine, University of Chicago Medical Center
Katerina Politi, PhD: Associate Professor, Yale School of Medicine
Nicholson Price, JD, PhD: Assistant Professor of Law, University of Michigan Law School
Gregory Raskin, MD: Vice President, Technology Development, Memorial Sloan Kettering Cancer Center; Lecturer, Yale College
Jessica Roberts, JD: Associate Professor, George Butler Research Professor of Law, and Director of the Health Law and Policy Institute, University of Houston Law Center
Joseph Ross, MD, MHS: Associate Professor of Medicine (General Medicine) and Associate Professor of Public Health (Health Policy), Yale School of Medicine
Eugene Rusyn, JD: Lecturer in Law and Senior Fellow, Solomon Center for Health Law and Policy, Yale Law School
Charles Sawyers, MD: Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
Richard Schilsky, MD: Chief Medical Officer, American Society of Clinical Oncology
Joseph Schlessinger, PhD: William H. Prusoff Professor of Pharmacology and Chair, Department of Pharmacology, Yale School of Medicine; Co-Director, Yale Cancer Biology Institute
Deborah Schrag, MD, MPH: Chief, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
Jeffrey Schwartz, MBA: Managing Director, Bain Capital Life Sciences
Ellen Sigal, PhD: Chairperson and Founder, Friends of Cancer Research
James Stansel, JD: Executive Vice President and General Counsel, PhRMA
Harold Varmus, MD: Lewis Thomas University Professor of Medicine, Weill Cornell Medicine; Nobel Prize Laureate; Former Director of the National Cancer Institute and the National Institutes of Health; and former President and CEO of Memorial Sloan Kettering Cancer Center
Lindsay Wiley, JD, MPH: Professor of Law and Director, Health Law and Policy Program, American University Washington College of Law
Agenda
All events listed below will take place at Yale Law School (127 Wall St., New Haven, CT)
Thursday, February 8, 2018
3:00 p.m. – 4:00 p.m.
Registration and Refreshments
Venue: Ruttenberg Dining Hall
4:00 p.m.
Welcome & Opening Remarks
Venue: Levinson Auditorium
Heather Gerken, JD—Dean and Sol & Lillian Goldman Professor of Law, Yale Law School
4:10 p.m. – 5:30 p.m.
Panel 1: Is the Federal Government a Productive Partner in Cancer Policy?
Venue: Levinson Auditorium
Moderator:
- Abbe Gluck, JD—Professor of Law and Faculty Director, Solomon Center for Health Law and Policy, Yale Law School
Panelists:
- Erik Fatemi—Senior Vice President, Cornerstone Government Affairs
- Nancy Goodman, JD, MPP—Executive Director, Kids v Cancer
- Peggy Hamburg, MD—Former Commissioner of the FDA (2009-2015)
- Richard Schilsky, MD—Chief Medical Officer, American Society of Clinical Oncology
- Harold Varmus, MD—Lewis Thomas University Professor of Medicine, Weill Cornell Medicine. Former Director of the National Cancer Institute and the National Institutes of Health, and former President and CEO of Memorial Sloan Kettering Cancer Center
Invited Commentators:
- Robert Bazell, PhD—Professor (Adjunct) of Molecular, Cellular, and Developmental Biology, Yale University
- Patricia LoRusso, DO—Professor of Medicine (Medical Oncology), Yale School of Medicine; Associate Director of Experimental Therapeutics at Yale Cancer Center
5:30 p.m. – 6:45 p.m.
Keynote Address
Venue: Levinson Auditorium
Siddhartha Mukherjee, MD, DPhil—Pulitzer Prize-Winning Author of The Emperor of All Maladies and Assistant Professor of Medicine, Columbia University Medical Center
Introduced by:
Charles Fuchs, MD, MPH—Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
6:45 p.m. – 7:30 p.m.
Reception
Venue: Ruttenberg Dining Hall
Friday, February 9, 2018
8:00 a.m. – 8:45 a.m.
Registration and Breakfast
Venue: Room 122
Friday’s panels will take place in the Levinson Auditorium.
8:45 a.m. – 10:15 a.m.
Panel 2: The Business of Cancer
Moderator:
- Howard Forman, MD, MBA—Professor of Radiology and Biomedical Imaging, Public Health (Health Policy), Management, and Economics at Yale University
Panelists:
- Ed Benz, MD—President and CEO Emeritus, Dana-Farber Cancer Institute
- Abe Lopman, MBA—Senior Vice President, Operations; Executive Director, Smilow Cancer Hospital at Yale New Haven
- Barbara McAneny, MD—Co-Founder and CEO, New Mexico Oncology Hematology Consultants; President-Elect, American Medical Association
- Lee Newcomer, MD, MHA—Senior Vice President, Oncology, Genetics and Women’s Health, UnitedHealthcare
- Randall Oyer, MD—Medical Director, Oncology Program, Lancaster General Hospital
Invited Commentators:
- Rogerio Lilenbaum, MD—Professor of Medicine (Medical Oncology), Yale School of Medicine; Chief Medical Officer of Smilow Cancer Hospital
- Gregory Raskin, MD—Vice President, Technology Development, Memorial Sloan Kettering Cancer Center; Lecturer, Yale College
10:15 a.m. – 10:30 a.m.
Coffee Break
10:30 a.m. – 12:00 p.m.
Panel 3: Cancer, Health Justice, and Disparities
Moderators:
- Cary Gross, MD—Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases), Yale School of Medicine
- Eugene Rusyn, JD—Yale Law School
Panelists:
- Otis Brawley, MD—Chief Medical Officer, American Cancer Society
- Dayna Bowen Matthew, JD—William J. Matheson and Robert M. Morgenthau Distinguished Professor of Law, University of Virginia School of Law
- Blase Polite, MD—Associate Professor of Medicine, University of Chicago Medical Center
- Deborah Schrag, MD, MPH—Chief, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School
- Lindsay Wiley, JD, MPH—Professor of Law and Director, Health Law and Policy, Program, American University Washington College of Law
Invited Commentators:
- Melinda Irwin, PhD, MPH—Professor of Epidemiology (Chronic Diseases), Yale School of Public Health; Associate Director (Population Sciences), Yale Cancer Center; Co-Program Leader, Cancer Prevention and Control, Yale Cancer Center
- Katerina Politi, PhD—Associate Professor, Yale School of Medicine
12:00 p.m. – 12:45 p.m.
Lunch
Venue: Ruttenberg Dining Hall
12:45 p.m. – 1:30 p.m.
Lunch Keynote
Venue: Levinson Auditorium
Norman Sharpless, MD—Director, National Cancer Institute
1:45 p.m. – 3:15 p.m.
Panel 4: Drug Development and the Cost of Researching and Treating Cancer
Moderator/Panelist:
- Charles Fuchs, MD, MPH—Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital
Panelists:
- Peter Bach, MD, MAPP—Director of the Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
- Gideon Blumenthal, MD—Deputy Director (acting), Office of Hematology Oncology Products, U.S. Food and Drug Administration
- Levi Garraway, MD, PhD—Senior Vice President, Global Development & Medical Affairs, Eli Lilly; Director, Joint Center for Cancer Precision Medicine
- Amy Kapczynski, JD—Professor of Law and Faculty Director, Global Health Justice Partnership, Yale Law School
- Jeffrey Schwartz, MBA—Managing Director, Bain Capital Life Sciences
- Ellen Sigal, PhD—Chairperson and Founder, Friends of Cancer Research
Invited Commentators:
- Joseph Schlessinger, PhD—William H. Prusoff Professor of Pharmacology and Chair, Department of Pharmacology, Yale School of Medicine; Co-Director, Yale Cancer Biology Institute
- James Stansel, JD: Executive Vice President and General Counsel, PhRMA
3:15 p.m. – 3:30 p.m.
Coffee Break
3:30 p.m. – 5:00 p.m.
Panel 5: Legal and Policy Issues Associated with Cutting-Edge Cancer Treatments
Moderators:
- Abbe Gluck, JD—Professor of Law and Faculty Director, Solomon Center for Health Law and Policy, Yale Law School
- Joseph Ross, MD, MHS—Associate Professor of Medicine (General Medicine) and Associate Professor of Public Health (Health Policy), Yale School of Medicine
Panelists:
- Roy Herbst, MD, PhD—Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
- Jorge Lopez, Jr., JD—Executive Vice President and General Counsel, Memorial Sloan Kettering Cancer Center
- Nicholson Price, JD, PhD—Assistant Professor of Law, University of Michigan Law School
- Jessica Roberts, JD—Associate Professor and Director, Health Law & Policy Institute, University of Houston Law Center
- Charles Sawyers, MD—Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
Invited Commentator:
- Mark Barnes, JD—Partner, Ropes & Gray LLP; Visiting Lecturer, Yale Law School
5:00 p.m. – 6:00 p.m.
Closing Reception
Venue: Ruttenberg Dining Hall
(Heavy food to be served for those traveling immediately thereafter)
Co-Sponsors
Yale Cancer Center
Smilow Cancer Hospital at Yale New Haven
Yale Health Law and Policy Society (YHeLPS)
Yale Journal of Health Policy, Law, and Ethics
This event is supported by the Oscar M. Ruebhausen Fund at Yale Law School.